Distinguished in Leber Hereditary Optic Neuropathy (LHON)

Dr. Rudrani Banik

Ophthalmology
310 E 14th St, Suite 319 South, 
New York, NY 
Distinguished in Leber Hereditary Optic Neuropathy (LHON)
310 E 14th St, Suite 319 South, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rudrani Banik is an Ophthalmologist in New York, New York. Dr. Banik is rated as a Distinguished provider by MediFind in the treatment of Leber Hereditary Optic Neuropathy (LHON). Her top areas of expertise are Papilledema, Optic Nerve Atrophy, Leber Hereditary Optic Neuropathy (LHON), and Increased Intracranial Pressure.

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles and participated in 2 clinical trials in the study of Leber Hereditary Optic Neuropathy (LHON).

Specialties
Ophthalmology
Licenses
Ophthalmology in NY
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

310 E 14th St, Suite 319 South, New York, NY 10003

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Enrollment Status: Completed
Publish Date: April 21, 2023
Intervention Type: Drug
Study Phase: Phase 4
Randomized Trial of Medical Therapy (MT) vs. MT Plus Optic Nerve Sheath Fenestration vs. MT Plus Ventriculoperitoneal Cerebrospinal Fluid Shunting in Subjects With Idiopathic Intracranial Hypertension and Moderate to Severe Visual Loss
Randomized Trial of Medical Therapy (MT) vs. MT Plus Optic Nerve Sheath Fenestration vs. MT Plus Ventriculoperitoneal Cerebrospinal Fluid Shunting in Subjects With Idiopathic Intracranial Hypertension and Moderate to Severe Visual Loss
Enrollment Status: Terminated
Publish Date: June 16, 2022
Intervention Type: Drug, Procedure
Study Phase: Phase 3
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
Enrollment Status: Terminated
Publish Date: October 12, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Enrollment Status: Terminated
Publish Date: July 20, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

16 Total Publications

Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
Journal: Cell reports. Medicine
Published: July 03, 2023
Similar Doctors
Distinguished in Leber Hereditary Optic Neuropathy (LHON)
Dr. Daniel Y. Stegman
Ophthalmology
Distinguished in Leber Hereditary Optic Neuropathy (LHON)
Dr. Daniel Y. Stegman
Ophthalmology

Nj Eye And Ear, LLC

1016 Main Ave, 
Clifton, NJ 
 (12.5 miles away)
973-546-5700
Languages Spoken:
English, French, Hebrew, Hungarian, Romanian, Spanish
See accepted insurances
Accepting New Patients

Daniel Stegman is an Ophthalmologist in Clifton, New Jersey. Dr. Stegman is rated as a Distinguished provider by MediFind in the treatment of Leber Hereditary Optic Neuropathy (LHON). His top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Allergic Conjunctivitis, and Pterygium. Dr. Stegman is currently accepting new patients.

Distinguished in Leber Hereditary Optic Neuropathy (LHON)
Dr. Barrett Katz
Ophthalmology
Distinguished in Leber Hereditary Optic Neuropathy (LHON)
Dr. Barrett Katz
Ophthalmology
111 East 210th Street, Centennial Building, 
Bronx, NY 
 (11.7 miles away)
718-920-2020
Languages Spoken:
English
See accepted insurances

Barrett Katz is an Ophthalmologist in Bronx, New York. Dr. Katz is rated as an Advanced provider by MediFind in the treatment of Leber Hereditary Optic Neuropathy (LHON). His top areas of expertise are Leber Hereditary Optic Neuropathy (LHON), Optic Nerve Atrophy, and Increased Intracranial Pressure.

Advanced in Leber Hereditary Optic Neuropathy (LHON)
Dr. Sierra X. Jin
Ophthalmology
Advanced in Leber Hereditary Optic Neuropathy (LHON)
Dr. Sierra X. Jin
Ophthalmology

Nj Eye And Ear, LLC

1016 Main Ave, 
Clifton, NJ 
 (12.5 miles away)
973-546-5700
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients

Sierra Jin is an Ophthalmologist in Clifton, New Jersey. Dr. Jin is rated as an Advanced provider by MediFind in the treatment of Leber Hereditary Optic Neuropathy (LHON). Her top areas of expertise are Leber Hereditary Optic Neuropathy (LHON), Blepharitis, Pterygium, and Dry Eye Syndrome. Dr. Jin is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Banik's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile